Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 5FI5376A0X |
InChI Key | SSRDSYXGYPJKRR-ZDUSSCGKSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H17ClN2OS |
Molecular Weight | 320.85 |
AlogP | 3.38 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 32.34 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 21.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
- | 299 | - | - | 51 | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
250-390 | - | - | 4-10 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 3 | D000544 | ClinicalTrials |
Dementia | 3 | D003704 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Psychotic Disorders | 1 | D011618 | ClinicalTrials |
Kidney Diseases | 1 | D007674 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2151572 |
DrugBank | DB11726 |
FDA SRS | 5FI5376A0X |
Guide to Pharmacology | 6926 |
PDB | I33 |
PubChem | 46196517 |
SureChEMBL | SCHEMBL744767 |
ZINC | ZINC000095579362 |